How is autophagy measured?
Autophagy is measured by tracking the proteins and signalling steps that build and recycle autophagosomes. This page describes the readouts used in laboratory research, from LC3 and ULK1 to ATG13 and p62, and the models
How is autophagy measured?
Autophagy is measured by detecting the proteins and signalling events that assemble, cargo-load, and degrade autophagosomes. The core readouts in laboratory research are the autophagy-related (ATG) proteins, the lipidated form of microtubule-associated protein 1 light chain 3 (LC3-II), the cargo receptor p62/SQSTM1, and upstream kinases such as ULK1 and AMPK. Because autophagy is a dynamic flux process, a single static marker is not sufficient; researchers typically combine a marker of autophagosome number with a marker of lysosomal degradation, or use flux assays that report the rate at which cargo is delivered to lysosomes.
The work described here centres on the autophagy initiation complex and its regulation by ATG13, ULK1, and the ubiquitin-proteasome and autophagy-lysosomal pathways.
Research Studies
ATG13 and K63-linked polyubiquitination of MAVS in influenza A virus infection
ATG13 is a component of the autophagy initiation complex. In a study of influenza A virus (IAV) infection, ATG13 was found to restrict IAV replication while potentiating type I interferon signalling. Coimmunoprecipitation assays showed that ATG13 interacts with MAVS and recruits the E3 ubiquitin ligase ASB1 to catalyse K63-linked polyubiquitination at the K348 residue, amplifying the downstream antiviral signalling cascade [2]. This work links an autophagy-initiation protein to a ubiquitin-dependent antiviral mechanism, and it illustrates how autophagy proteins can be measured through their interaction partners and post-translational modifications rather than through autophagosome counts alone.
Astrocytic autophagy-lysosomal impairment in Parkinson's disease models
A system-level review of Parkinson's disease (PD) pathogenesis synthesised evidence that astrocyte dysfunction, or astrocytopathy, is a central driver rather than a passive bystander. In that model, pathological α-synuclein triggers a cycle of astrocytic failure that includes impaired proteostasis via the ubiquitin-proteasome and autophagy-lysosomal pathways, glymphatic collapse due to aquaporin-4 (AQP4) depolarisation, and chronic neuroinflammation driven by microglial crosstalk and NLRP3 inflammasome activation [1]. The autophagy-lysosomal pathway is therefore one of several measurable axes in this multicellular model, and the evidence is drawn from review-level synthesis of preclinical and human tissue studies rather than from a single assay.
LSD1, ATM demethylation, and senescence in aged organs
LSD1 was upregulated in aged organs and senescent cells. In response to natural ageing or ionising radiation-induced DNA damage, LSD1 interacted with and demethylated ATM at lysine 3,016, sustaining ATM phosphorylation and amplifying DNA damage signalling [3]. This study used a newly generated ATM-K3016me antibody to confirm the modification. Although the work centres on senescence rather than autophagy directly, it provides a template for how a post-translational modification can be measured with a modification-specific antibody, an approach also used for autophagy proteins such as LC3 and p62.
Fisetin and ULK1 binding in SH-SY5Y neuroblastoma cells
In silico studies demonstrated that fisetin binds strongly and with high stability to ULK1 (an autophagy marker), p21 (a senescence/cell cycle marker), and synaptophysin (a synaptic marker). These predictions were evaluated in an Aβ1-42-induced neurotoxicity model in human neuroblastoma SH-SY5Y cells [7]. This is an in vitro study, and the autophagy readout is ULK1 binding and downstream signalling rather than autophagic flux in vivo. It illustrates how computational target prediction can be paired with cell-based validation when measuring autophagy-related targets.
Astaxanthin and granulosa-cell autophagy in a pilot randomised trial
A triple-blind, placebo-controlled pilot randomised trial evaluated whether astaxanthin (AST) modulates autophagy-related signalling in granulosa cells (GCs) from women with polyendocrine metabolic ovarian syndrome (PMOS)-related anovulatory infertility. Fifty women were enrolled between November 2023 and September 2024 and received AST (12 mg/day) or placebo [6]. The study measured autophagy-related signalling in GCs and related these molecular effects to ovarian response. This is a human pilot trial, but the sample size is small and the findings are preliminary; the autophagy readouts are molecular markers in retrieved cells, not a clinical endpoint.
Fasting, exercise, and diet to activate autophagy in depression
A registered clinical study aims to understand how lifestyle factors such as physical activity and diet-related processes may influence biological mechanisms linked to depression. The study focuses on autophagy, a natural cellular process that helps cells remove damaged components, and notes that autophagy is influenced by energy availability and may be affected by behaviours such as physical exercise and caloric restriction [5]. This is a study protocol rather than a completed trial, and it does not yet report measured autophagy values. It is included here because it shows how autophagy is being framed as a measurable biological mechanism in human behavioural research.
Inorganic phosphate and skeletal muscle energetics
A review of inorganic phosphate (Pi) additives in ultra-processed foods reported that habitual Pi intake exceeds the recommended daily allowance by two- to three-fold in many western populations, and that chronic Pi excess may impair skeletal muscle energetics [8]. The review links this to exercise intolerance. Autophagy is not the primary readout in this paper, but the work is relevant to measurement because it shows how dietary exposures can be quantified and related to cellular quality-control pathways in muscle. The evidence is review-level and does not provide a direct autophagy assay.
Natural medicines for Alzheimer's disease: bibliometric and narrative synthesis
A bibliometric analysis and narrative review mapped research on natural medicines for Alzheimer's disease (AD) using publications in the Web of Science Core Collection from January 1, 2001, to April 28, 2025, analysed with VOSviewer and CiteSpace. Bibliometric findings guided a focused narrative synthesis of original experimental studies [4]. The review does not report a single autophagy measurement; instead, it characterises the field in which autophagy is one of several mechanistic themes. It is included here to show how measurement approaches are distributed across the literature rather than to provide a specific assay protocol.
Autophagy in hypothalamic POMC and AgRP neurons
Within the arcuate nucleus, autophagy exerts divergent metabolic effects in the two principal appetite-regulating neuronal populations, POMC and AgRP neurons. This work frames obesity as a disorder involving impaired central endocrine regulation in which hypothalamic nutrient sensing, leptin responsiveness, and intracellular quality control are intertwined [9]. The evidence is preclinical and supports the broader point that autophagy measurement in the brain must be cell-type specific, because the same pathway can have opposite effects in adjacent neuronal populations.
Hepassocin, AMPK, and liver senescence
Hepassocin (HPS) is a hepatokine with known hepatoprotective functions. A study reported that HPS prevents age-related liver senescence and facilitates liver regeneration by activating AMPK [10]. AMPK is an upstream regulator of autophagy, so this work is relevant to measurement because it shows how a secreted factor can be linked to an energy-sensing kinase that in turn influences autophagic flux. The evidence is preclinical.
Radiation-induced atrial fibrillation and senolytic rescue
Radiation-induced heart disease is a recognised complication of thoracic radiotherapy, with atrial fibrillation (AF) being a notable sequela. A study investigated how ionising radiation heightens AF susceptibility and reported that cellular senescence via the GATA4-NF-κB pathway drives the effect, which was rescued by D/Q senolytic therapy [11]. Senescence and autophagy are related quality-control responses, and this work shows how a senescence readout can be paired with a pharmacological intervention to test causality. The evidence is preclinical.
Prevotella intermedia supernatant and alveolar macrophage function
Microbiome analyses using 16S ribosomal RNA gene sequencing have revealed a higher prevalence of Prevotella species in patients with nontuberculous mycobacterial pulmonary disease (NTM-PD) than in those with non-NTM-PD bronchiectasis. Prevotella intermedia culture supernatant has been reported to impair alveolar macrophage function and promote Mycobacterium avium persistence [12]. Macrophage autophagy is a key host-defence mechanism against intracellular mycobacteria, so this work is relevant to measurement because it shows how a microbial exposure can be linked to impaired macrophage quality control. The evidence is preclinical and does not report a direct autophagy assay.
Comparison of common autophagy readouts
| Readout | What it reports | Model or context in the evidence |
|---|---|---|
| LC3-II | Autophagosome number | General cell and tissue studies; not directly reported in the cited evidence |
| p62/SQSTM1 | Cargo receptor levels; often inversely related to flux | General cell and tissue studies; not directly reported in the cited evidence |
| ULK1 binding | Upstream initiation complex engagement | In silico prediction in SH-SY5Y cells [7] |
| ATG13-MAVS interaction | Autophagy protein interaction and K63 ubiquitination | Influenza A virus infection model [2] |
| Autophagy-lysosomal pathway impairment | Proteostasis failure in astrocytes | Parkinson's disease system-level review [1] |
| Autophagy-related signalling in granulosa cells | Molecular response to astaxanthin | Pilot randomised trial in PMOS-related infertility [6] |
If you are reading this for personal health reasons
The compounds and pathways described on this page are sold for laboratory research use only. We do not provide dosing, medical guidance, or treatment advice. Anyone considering a compound for themselves should speak to a licensed clinician.
Sources
- [1] Convergent Astrocytic Failure in Parkinson's Disease: A System-Level Model of Pathogenesis and Treatment
- [2] ATG13 promotes K63-linked polyubiquitination of MAVS via ASB1 to restrict influenza A virus replication
- [3] LSD1-mediated demethylation of the DNA damage response factor ATM promotes senescence and organ aging
- [4] Research Trends and Mechanistic Insights Into Natural Medicines for Alzheimer's Disease: A Bibliometric Analysis and Narrative Review
- [5] Fasting, Exercise, and Diet to Activate Autophagy in Depression
- [6] Autophagy activation in granulosa cells as a mechanism of astaxanthin action: evidence from a pilot randomised trial in PMOS-associated infertility
- [7] Fisetin Attenuates Amyloid-Beta-Induced Neurotoxicity in Human Neuroblastoma SH-SY5Y Cells: Integrating In Silico Target Prediction and In Vitro Validation
- [8] Inorganic phosphate: a link between processed food and exercise intolerance in the modern world
- [9] Autophagy in hypothalamic POMC and AgRP neurons: mechanisms and therapeutic implications for obesity
- [10] Hepassocin prevents age-related liver senescence and facilitates liver regeneration by activating AMPK
- [11] Radiation-induced atrial fibrillation is driven by cellular senescence via the GATA4 - NF-κB pathway and rescued by D/Q senolytic therapy
- [12] Prevotella intermedia culture supernatant impairs alveolar macrophage function and promotes Mycobacterium avium persistence